NCT02960646 2023-02-16Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed11 enrolled
NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts